Stemedica Cell Technologies, Inc Revenue

Biotechnology Research • San Diego, California, United States • 21-50 Employees

Stemedica Cell Technologies, Inc revenue & valuation

Annual revenue	$8,000,000
Revenue per employee	$250,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$25,600,000
Total funding	$22,000,000

Key Contacts at Stemedica Cell Technologies, Inc

Alexander Kharazi

Chief Technology Officer

Eugene Baranov

Director Of Research Development

Company overview

Headquarters	San Diego, California, United States
Phone number	+18586580910
Website	stemedica.com
NAICS	541714
SIC	873
Founded	2005
Employees	21-50
Socials

Stemedica Cell Technologies, Inc Email Formats

Stemedica Cell Technologies, Inc uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@stemedica.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@stemedica.com	100%

About Stemedica Cell Technologies, Inc

Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions. Stemedica has developed a proprietary manufacturing technology platform that produces allogeneic progenitor cell products with intellectual property protection under a low-oxygen, low-tension environment in a cGMP-compliant manufacturing facility. The company's lead drug candidate, ischemia-tolerant mesenchymal stem cells, or itMSCs, is an allogeneic progenitor cell therapy currently in clinical development for the treatment of ischemic stroke and Alzheimer’s disease. The company’s second drug candidate, ischemia-tolerant neural progenitor cells, or itNSCs, is an allogeneic cell therapy currently in development for spinal cord injury. In addition, Stemedica is developing progenitor multi-cell therapy (itMSCs and itNSCs) for ischemic stroke and progenitor cell and protein combination therapy for Alzheimer’s disease. More information on Stemedica may be found at www.stemedica.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Vice President

Employees by Department

Stemedica Cell Technologies, Inc has 7 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Stemedica Cell Technologies, Inc's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2010-01-31	5	$22,000,000

Funding Insights

$22,000,000

Total funding amount

$22,000,000

Most recent funding amount

Number of funding rounds

Stemedica Cell Technologies, Inc Tech Stack

Discover the technologies and tools that power Stemedica Cell Technologies, Inc's digital infrastructure, from frameworks to analytics platforms.

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

LiteSpeed

Web servers

Google Tag Manager

Tag managers

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Divi

Page builders

Google Analytics

Analytics

Google Maps

Maps

MySQL

Databases

RSS

Miscellaneous

Frequently asked questions

Stemedica Cell Technologies, Inc is located in San Diego, California, US.

You can reach Stemedica Cell Technologies, Inc at +18586580910.

Stemedica Cell Technologies, Inc generates an estimated annual revenue of $8,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Stemedica Cell Technologies, Inc has an estimated valuation of $25,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Stemedica Cell Technologies, Inc was founded in 2005, making it 21 years old. The company has established itself as a significant player in its industry over this time.

Stemedica Cell Technologies, Inc has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Stemedica Cell Technologies, Inc has raised a total of $22,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Stemedica Cell Technologies, Inc

Alexander Kharazi

Chief Technology Officer

Eugene Baranov

Director Of Research Development

4.8

40,000 users